June 1, 2020 / 11:30 AM / a month ago

BRIEF-HHS - Emergent To Commit Manufacturing Capacity For Production Of Covid-19 Vaccine Candidates

June 1 (Reuters) - Emergent BioSolutions Inc:

* HHS ADDS $628 MILLION TO CONTRACT WITH EMERGENT BIOSOLUTIONS TO SECURE CDMO MANUFACTURING CAPACITY FOR OPERATION WARP SPEED

* HHS - ANNOUNCED TASK ORDER WITH EMERGENT BIOSOLUTIONS TO ADVANCE MANUFACTURING CAPABILITIES, CAPACITY FOR POTENTIAL COVID-19 VACCINE, THERAPEUTICS

* HHS - EMERGENT TO COMMIT CDMO DRUG SUBSTANCE & DRUG PRODUCT MANUFACTURING CAPACITY OF ABOUT $542.75 MILLION FOR PRODUCTION OF COVID-19 VACCINE CANDIDATESSource text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below